Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000376863 | SCV000385065 | uncertain significance | Intellectual Disability, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000286877 | SCV000385066 | uncertain significance | Autosomal dominant cerebellar ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000342108 | SCV000385067 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000604803 | SCV000722003 | likely benign | not specified | 2017-08-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002520890 | SCV001004375 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-09-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003456392 | SCV004184426 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | DYNC1H1: BP4, BP7 |